Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-02-16 4:33 pm Purchase |
2020-12-31 | 13G | CRISPR Therapeutics AG CRSP |
ARK Investment Management LLC | 10,412,976 14.620% |
1,955,656 (+23.12%) |
Filing History |
| 2021-02-16 3:58 pm Purchase |
2021-02-16 | 13G | CRISPR Therapeutics AG CRSP |
Capital International Investors | 7,626,355 10.700% |
106,552 (+1.42%) |
Filing History |
| 2021-02-16 07:33 am Purchase |
2020-09-29 | 13D | CRISPR Therapeutics AG CRSP |
Versant Ventures IV LLC | 1,344,010 1.900% |
1,344,010 (New Position) |
Filing History |
| 2021-02-11 5:14 pm Purchase |
2020-12-31 | 13G | CRISPR Therapeutics AG CRSP |
Nikko Asset Management Americas, Inc. | 3,836,823 5.390% |
787,270 (+25.82%) |
Filing History |
| 2021-02-05 06:10 am Purchase |
2020-12-31 | 13G | CRISPR Therapeutics AG CRSP |
Sumitomo Mitsui Trust Group, Inc. | 3,836,823 5.390% |
786,938 (+25.80%) |
Filing History |
| 2020-10-09 1:51 pm Purchase |
2020-06-30 | 13G | CRISPR Therapeutics AG CRSP |
ARK Investment Management LLC | 8,457,320 12.050% |
8,457,320 (New Position) |
Filing History |
| 2020-09-18 5:05 pm Purchase |
2020-09-09 | 13D | CRISPR Therapeutics AG CRSP |
Versant Venture Capital IV L.P. | 2,087,120 3.000% |
2,087,120 (New Position) |
Filing History |
| 2020-09-11 11:04 am Unchanged |
2020-09-10 | 13G | CRISPR Therapeutics AG CRSP |
Capital International Investors | 7,519,803 10.700% |
0 (Unchanged) |
Filing History |
| 2020-09-10 2:54 pm Purchase |
2020-09-10 | 13G | CRISPR Therapeutics AG CRSP |
Capital International Investors | 7,519,803 10.700% |
7,519,803 (New Position) |
Filing History |
| 2020-07-10 5:26 pm Purchase |
2020-07-06 | 13D | CRISPR Therapeutics AG CRSP |
GLAXOSMITHKLINE PLC | 3,310,627 4.800% |
15,000 (+0.46%) |
Filing History |